4/24
10:20 am
pgen
Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting
Low
Report
Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting
3/28
04:19 pm
pgen
Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th [Yahoo! Finance]
Low
Report
Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th [Yahoo! Finance]
3/28
04:05 pm
pgen
Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th
Low
Report
Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th
3/26
05:30 am
pgen
Precigen, Inc. (NASDAQ: PGEN) was upgraded by analysts at StockNews.com to a "sell" rating.
High
Report
Precigen, Inc. (NASDAQ: PGEN) was upgraded by analysts at StockNews.com to a "sell" rating.
3/22
11:12 am
pgen
J.P. Morgan cuts Precigen to underweight, cites burn rate [Seeking Alpha]
Low
Report
J.P. Morgan cuts Precigen to underweight, cites burn rate [Seeking Alpha]
3/22
08:11 am
pgen
Precigen, Inc. (NASDAQ: PGEN) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.
Medium
Report
Precigen, Inc. (NASDAQ: PGEN) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.
3/20
10:36 am
pgen
Precigen, Inc. (NASDAQ: PGEN) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $14.00 price target on the stock.
Low
Report
Precigen, Inc. (NASDAQ: PGEN) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $14.00 price target on the stock.
3/20
10:17 am
pgen
Precigen, Inc. (NASDAQ:PGEN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Precigen, Inc. (NASDAQ:PGEN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/20
08:08 am
pgen
Precigen, Inc. (NASDAQ: PGEN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Low
Report
Precigen, Inc. (NASDAQ: PGEN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
3/19
04:19 pm
pgen
Precigen Reports Full Year 2023 Financial Results and Business Updates [Yahoo! Finance]
Low
Report
Precigen Reports Full Year 2023 Financial Results and Business Updates [Yahoo! Finance]
3/19
04:05 pm
pgen
Precigen Reports Full Year 2023 Financial Results and Business Updates
Low
Report
Precigen Reports Full Year 2023 Financial Results and Business Updates
3/12
04:15 pm
pgen
Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis [Yahoo! Finance]
Low
Report
Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis [Yahoo! Finance]
3/12
04:05 pm
pgen
Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis
Low
Report
Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis
3/8
06:12 am
pgen
Precigen, Inc.'s (NASDAQ:PGEN) top owners are private equity firms with 38% stake, while 30% is held by institutions [Yahoo! Finance]
Medium
Report
Precigen, Inc.'s (NASDAQ:PGEN) top owners are private equity firms with 38% stake, while 30% is held by institutions [Yahoo! Finance]
3/5
04:05 pm
pgen
Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th
Medium
Report
Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th
2/20
01:37 pm
pgen
Precigen, Inc. (NASDAQ:PGEN): When Will It Breakeven? [Yahoo! Finance]
Low
Report
Precigen, Inc. (NASDAQ:PGEN): When Will It Breakeven? [Yahoo! Finance]
2/9
10:26 am
pgen
Synthetic Biology Market size worth $ 63.78 Billion, Globally, by 2030 at 22.33% CAGR – Report By Verified Market Research® [Yahoo! Finance]
Low
Report
Synthetic Biology Market size worth $ 63.78 Billion, Globally, by 2030 at 22.33% CAGR – Report By Verified Market Research® [Yahoo! Finance]
2/6
04:14 pm
pgen
Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
Low
Report
Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
2/6
04:05 pm
pgen
Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Medium
Report
Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
2/6
01:07 am
pgen
Precigen, Inc. (NASDAQ: PGEN) was upgraded by analysts at StockNews.com to a "sell" rating.
Low
Report
Precigen, Inc. (NASDAQ: PGEN) was upgraded by analysts at StockNews.com to a "sell" rating.
2/4
08:10 am
pgen
Insider Stock Buying Reaches US$1.72m On Precigen [Yahoo! Finance]
Low
Report
Insider Stock Buying Reaches US$1.72m On Precigen [Yahoo! Finance]
1/31
10:03 pm
pgen
Precigen, Inc. (NASDAQ: PGEN) was upgraded by analysts at StockNews.com to a "sell" rating.
Low
Report
Precigen, Inc. (NASDAQ: PGEN) was upgraded by analysts at StockNews.com to a "sell" rating.